Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
54
BBP Quote, Financials, Valuation and Earnings
Last price:
$83.30
Seasonality move
:
-1.52%
Day range:
$83.20 - $84.04
52-week range:
$48.65 - $85.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
3.5K
Avg. volume:
4.5K
1-year change:
31.4%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
-- | -- | -- | -- | -- |
|
PFFR
InfraCap REIT Preferred ETF
|
-- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- |
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BBP
Virtus LifeSci Biotech Products ETF
|
$83.88 | -- | -- | -- | $0.00 | 0% | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
$40.82 | -- | -- | -- | $0.66 | 1.61% | -- |
|
PFFR
InfraCap REIT Preferred ETF
|
$18.17 | -- | -- | -- | $0.12 | 7.96% | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
$43.11 | -- | -- | -- | $0.00 | 0.09% | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
$48.92 | -- | -- | -- | $1.53 | 3.12% | -- |
|
XBI
State Street SPDR S&P Biotech ETF
|
$124.78 | -- | -- | -- | $0.41 | 0.36% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | 0.427 | -- | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
-- | 1.655 | -- | -- |
|
PFFR
InfraCap REIT Preferred ETF
|
-- | 0.257 | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | 0.335 | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | 0.438 | -- | -- |
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | 0.972 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BBP
Virtus LifeSci Biotech Products ETF
|
-- | -- | -- | -- | -- | -- |
|
BBC
Virtus LifeSci Biotech Clinical Trials ETF
|
-- | -- | -- | -- | -- | -- |
|
PFFR
InfraCap REIT Preferred ETF
|
-- | -- | -- | -- | -- | -- |
|
PSCH
Invesco S&P SmallCap Health Care ETF
|
-- | -- | -- | -- | -- | -- |
|
PTH
Invesco Dorsey Wright Healthcare Momentum ETF
|
-- | -- | -- | -- | -- | -- |
|
XBI
State Street SPDR S&P Biotech ETF
|
-- | -- | -- | -- | -- | -- |
Virtus LifeSci Biotech Products ETF vs. Competitors
-
Which has Higher Returns BBP or BBC?
Virtus LifeSci Biotech Clinical Trials ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat Virtus LifeSci Biotech Clinical Trials ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- BBCVirtus LifeSci Biotech Clinical Trials ETF-- -- -- -
What do Analysts Say About BBP or BBC?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Virtus LifeSci Biotech Clinical Trials ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than Virtus LifeSci Biotech Clinical Trials ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than Virtus LifeSci Biotech Clinical Trials ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 BBCVirtus LifeSci Biotech Clinical Trials ETF0 0 0 -
Is BBP or BBC More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.654, which suggesting that the stock is 34.618% less volatile than S&P 500. In comparison Virtus LifeSci Biotech Clinical Trials ETF has a beta of 0.996, suggesting its less volatile than the S&P 500 by 0.354%.
-
Which is a Better Dividend Stock BBP or BBC?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Virtus LifeSci Biotech Clinical Trials ETF offers a yield of 1.61% to investors and pays a quarterly dividend of $0.66 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. Virtus LifeSci Biotech Clinical Trials ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or BBC?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than Virtus LifeSci Biotech Clinical Trials ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than Virtus LifeSci Biotech Clinical Trials ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while Virtus LifeSci Biotech Clinical Trials ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for Virtus LifeSci Biotech Clinical Trials ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- BBCVirtus LifeSci Biotech Clinical Trials ETF-- -- -- --
-
Which has Higher Returns BBP or PFFR?
InfraCap REIT Preferred ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat InfraCap REIT Preferred ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- PFFRInfraCap REIT Preferred ETF-- -- -- -
What do Analysts Say About BBP or PFFR?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand InfraCap REIT Preferred ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than InfraCap REIT Preferred ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than InfraCap REIT Preferred ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 PFFRInfraCap REIT Preferred ETF0 0 0 -
Is BBP or PFFR More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.654, which suggesting that the stock is 34.618% less volatile than S&P 500. In comparison InfraCap REIT Preferred ETF has a beta of 0.718, suggesting its less volatile than the S&P 500 by 28.238%.
-
Which is a Better Dividend Stock BBP or PFFR?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. InfraCap REIT Preferred ETF offers a yield of 7.96% to investors and pays a quarterly dividend of $0.12 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. InfraCap REIT Preferred ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or PFFR?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than InfraCap REIT Preferred ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than InfraCap REIT Preferred ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while InfraCap REIT Preferred ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for InfraCap REIT Preferred ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- PFFRInfraCap REIT Preferred ETF-- -- -- --
-
Which has Higher Returns BBP or PSCH?
Invesco S&P SmallCap Health Care ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat Invesco S&P SmallCap Health Care ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- -
What do Analysts Say About BBP or PSCH?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco S&P SmallCap Health Care ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than Invesco S&P SmallCap Health Care ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than Invesco S&P SmallCap Health Care ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 PSCHInvesco S&P SmallCap Health Care ETF0 0 0 -
Is BBP or PSCH More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.654, which suggesting that the stock is 34.618% less volatile than S&P 500. In comparison Invesco S&P SmallCap Health Care ETF has a beta of 0.940, suggesting its less volatile than the S&P 500 by 6.013%.
-
Which is a Better Dividend Stock BBP or PSCH?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Invesco S&P SmallCap Health Care ETF offers a yield of 0.09% to investors and pays a quarterly dividend of $0.00 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. Invesco S&P SmallCap Health Care ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or PSCH?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than Invesco S&P SmallCap Health Care ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than Invesco S&P SmallCap Health Care ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while Invesco S&P SmallCap Health Care ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for Invesco S&P SmallCap Health Care ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- PSCHInvesco S&P SmallCap Health Care ETF-- -- -- --
-
Which has Higher Returns BBP or PTH?
Invesco Dorsey Wright Healthcare Momentum ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat Invesco Dorsey Wright Healthcare Momentum ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- -
What do Analysts Say About BBP or PTH?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand Invesco Dorsey Wright Healthcare Momentum ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than Invesco Dorsey Wright Healthcare Momentum ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than Invesco Dorsey Wright Healthcare Momentum ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 PTHInvesco Dorsey Wright Healthcare Momentum ETF0 0 0 -
Is BBP or PTH More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.654, which suggesting that the stock is 34.618% less volatile than S&P 500. In comparison Invesco Dorsey Wright Healthcare Momentum ETF has a beta of 0.937, suggesting its less volatile than the S&P 500 by 6.297%.
-
Which is a Better Dividend Stock BBP or PTH?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Invesco Dorsey Wright Healthcare Momentum ETF offers a yield of 3.12% to investors and pays a quarterly dividend of $1.53 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. Invesco Dorsey Wright Healthcare Momentum ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or PTH?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than Invesco Dorsey Wright Healthcare Momentum ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than Invesco Dorsey Wright Healthcare Momentum ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while Invesco Dorsey Wright Healthcare Momentum ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for Invesco Dorsey Wright Healthcare Momentum ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- PTHInvesco Dorsey Wright Healthcare Momentum ETF-- -- -- --
-
Which has Higher Returns BBP or XBI?
State Street SPDR S&P Biotech ETF has a net margin of -- compared to Virtus LifeSci Biotech Products ETF's net margin of --. Virtus LifeSci Biotech Products ETF's return on equity of -- beat State Street SPDR S&P Biotech ETF's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BBPVirtus LifeSci Biotech Products ETF-- -- -- XBIState Street SPDR S&P Biotech ETF-- -- -- -
What do Analysts Say About BBP or XBI?
Virtus LifeSci Biotech Products ETF has a consensus price target of --, signalling downside risk potential of --. On the other hand State Street SPDR S&P Biotech ETF has an analysts' consensus of -- which suggests that it could fall by --. Given that Virtus LifeSci Biotech Products ETF has higher upside potential than State Street SPDR S&P Biotech ETF, analysts believe Virtus LifeSci Biotech Products ETF is more attractive than State Street SPDR S&P Biotech ETF.
Company Buy Ratings Hold Ratings Sell Ratings BBPVirtus LifeSci Biotech Products ETF0 0 0 XBIState Street SPDR S&P Biotech ETF0 0 0 -
Is BBP or XBI More Risky?
Virtus LifeSci Biotech Products ETF has a beta of 0.654, which suggesting that the stock is 34.618% less volatile than S&P 500. In comparison State Street SPDR S&P Biotech ETF has a beta of 0.945, suggesting its less volatile than the S&P 500 by 5.483%.
-
Which is a Better Dividend Stock BBP or XBI?
Virtus LifeSci Biotech Products ETF has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. State Street SPDR S&P Biotech ETF offers a yield of 0.36% to investors and pays a quarterly dividend of $0.41 per share. Virtus LifeSci Biotech Products ETF pays -- of its earnings as a dividend. State Street SPDR S&P Biotech ETF pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BBP or XBI?
Virtus LifeSci Biotech Products ETF quarterly revenues are --, which are smaller than State Street SPDR S&P Biotech ETF quarterly revenues of --. Virtus LifeSci Biotech Products ETF's net income of -- is lower than State Street SPDR S&P Biotech ETF's net income of --. Notably, Virtus LifeSci Biotech Products ETF's price-to-earnings ratio is -- while State Street SPDR S&P Biotech ETF's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Virtus LifeSci Biotech Products ETF is -- versus -- for State Street SPDR S&P Biotech ETF. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BBPVirtus LifeSci Biotech Products ETF-- -- -- -- XBIState Street SPDR S&P Biotech ETF-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Sell
50
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
77
RNG alert for Feb 21
RingCentral, Inc. [RNG] is up 34.37% over the past day.
Sell
9
FROG alert for Feb 21
JFrog Ltd. [FROG] is down 24.98% over the past day.
Buy
72
SNSE alert for Feb 21
Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.
